References
Osterziel KJ, Dietz R, Harder K, Kubler W. Comparison of captopril with enalapril in the treatment of heart failure: Influence on hemodynamics and measures of renal function. Cardiovasc Drugs Ther 1992;6:173–180.
Packer M, Lee WH, Yushak M, Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986;315:847–853.
SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.
Cohn JN, Johnson G, Ziesche S, et al. Comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325: 303–310.
Pouleur H, Rousseau MF, Oakley C, Ryden L the Xamotherol in Severe Heart Failure Study Group. Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol 1991;68:71–74.
Schofield PM, Brooks NH, Lawrence GP, et al. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine. Br J Clin Pharmacol 1991;31:25–32.
Brilla CG, Kramer B, Hoffmeister HM, et al. Low-dose analapril in severe chronic heart failure. Cardiovasc Drugs Ther 1989;3:211–218.
Rights and permissions
About this article
Cite this article
Choice of ACE inhibitor for congestive heart failure. Cardiovasc Drug Ther 6, 181 (1992). https://doi.org/10.1007/BF00054568
Issue Date:
DOI: https://doi.org/10.1007/BF00054568